Alterity Therapeutics Limited (ASX:ATH, NASDAQ:ATHE) today announced that its Board of Directors approved a ratio change of its American Depository Shares (ADSs) to Ordinary Shares (the "ADS Ratio") from the current ADS Ratio of 1 ADS representing 60 Ordinary Shares to 1 ADS representing 600 Ordinary Shares (the "ADS Ratio Change"). The ADS Ratio Change will be effective on January 9, 2023.
NextPlay Technologies, Inc. (NASDAQ:NXTP), a digital native ecosystem for finance, digital advertisers, and video gamers, announced that its Board of Directors has declared a 1-for-20 reverse stock split of the
Tenax Therapeutics, Inc. (NASDAQ:TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need,
Oblong, Inc. (NASDAQ:OBLG) ("Oblong" or the "Company"), the award-winning maker of multi-stream collaboration solutions, announced today that it has filed an amendment to its certificate of
New York City REIT, Inc. (NYSE: NYC) ("NYC" or the "Company") announced today that it intends to expand the scope of the assets and businesses the Company may own and operate.
NuZee, Inc. (NASDAQ:NUZE) ("NuZee" or "the Company"), a leading U.S. producer and co-packer of single serve coffee formats, announced today that it intends to effect a 1-for-35 reverse stock split of